Header Logo

Connection

SHANNON RONCA to Immunoglobulin G

Back to Details
This is a "connection" page, showing publications SHANNON RONCA has written about Immunoglobulin G.
SHANNON RONCA
Connection Strength
0.121
Immunoglobulin G
  1. A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452. Vaccine. 2023 03 24; 41(13):2184-2197.
    View in: PubMed
    Score: 0.042
  2. Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452. Vaccine. 2022 02 23; 40(9):1253-1260.
    View in: PubMed
    Score: 0.039
  3. Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452. Vaccine. 2021 10 29; 39(45):6601-6613.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.